CD209/DC-SIGN Recombinant Antibody, Biotin Conjugated
Product Specifications
Background
Pathogen-recognition receptor expressed on the surface of immature dendritic cells (DCs) and involved in initiation of primary immune response. Thought to mediate the endocytosis of pathogens which are subsequently degraded in lysosomal compartments. The receptor returns to the cell membrane surface and the pathogen-derived antigens are presented to resting T-cells via MHC class II proteins to initiate the adaptive immune response.
Synonyms
CD209 antigen-like protein A; CDSIGN; CIRE; CLEC4L; DCSIGN; Dendritic cell specific ICAM 3 grabbing nonintegrin 1; HIV GP120 Binding Protein; SIGN-R1; SIGNR5.
Gene ID
30835
Swiss Prot
Q9NNX6
Cellular Locus
Secreted, Cell membrane
Host
Rabbit
Cross Reactivity
Human
Target
CD209/DC-SIGN
Clonality
Recombinant
Isotype
IgG
Conjugation
Biotin
Source
KLH conjugated synthetic peptide derived from human CD209
Applications
WB
Purification
Purified by Protein A.
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C for 12 months.
Gene ID URL
30835
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15307962 1 Vial
Lentiviral human LONP2 shRNA (UAS) - Lentiviral human LONP2 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details 
